Jemincare Announces the Exclusive License of the Kras Inhibito...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SHANGHAI, Nov. 30, 2021 /PRNewswire-AsiaNet/ -- Jemincare, a leading pharmaceutical company from China, announced today its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., had licensed exclusive worldwide ex-China rights to the Kras inhibitor, JMKX1899, to HUYABIO ...
Authors: LATEST ASIANET NEWS RELEASES